Uploaded on Jul 17, 2024
According to the latest research report by IMARC Group, The China genetic testing market size reached US$ 4.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.9 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2024-2032. More Info:- https://www.imarcgroup.com/china-genetic-testing-market
China Genetic Testing Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
China Genetic Testing Market Research and Forecast Report 2024- 2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . Acco r d ing t o t h e l a t es t r epo r t by I M A RC G r oup , t i t l e d " Ch i na G enet i c Tes t i ng M ar ke t : I nd ust ry T r ends , Sha re , S i ze , G row t h , O ppo r t un i t y a nd For ecas t 202 4 - 2032 , " t he Ch in a gen e t i c t es t i n g m a r ke t s i ze r eac hed US$ 4 . 3 B i l l i on i n 2023 . G en e t i c t es t s i den t i f y t he chan ges occu r r i ng i n t he g enes , p r o t e ins o r c h r om oso m es Report o f an i nd i v idu a l . The y he lp i n de t e r m in i ng t he chan ces o f a pe r son pas s ing on a gene t i c d i so r de r t o t h e nex t gene r a t i o n as w e l l as t he i r vu lne r a b i l i t y t o a su spec t ed gene t i c d i seas e . The gen e t i c t es t i ng m a r ke t i n Ch ina h as w i t ness ed r ap id Highlight and dev e l opm en t s ince t he es t ab l i shm e n t o f t he f i r s t ge nom ic s com pan y i n 1 999 . The dem and f o r ge ne t i c t es t i ng se r v i ces i n t he cou n t r y i s be ing d r i ven by f ac t o r s Description l i ke ag i ng p opu l a t i on , ex pan d ing m idd le c las s a nd in ves t m en t s i n t h e he a l t hc a r e sec t o r . The i nd us t r y h as a l so a t t r a c t ed i n t e r na t i o na l i n ves t o r s o w ing t o r i s i ng dem and f o r no n inva s i ve p r e na t a l t es t i ng and g r ow ing r ese a r ch i n t he f i e l ds o f r ep r oduc t i ve a nd o nco log y hea l t h . Reque st f o r a P DF s ampl e o f t h i s repor t : h t t p s : / / www. im ar c g r ou p . com / ch i na - gen e t i c - t es t i ng - m ar ke t / r eq ues t sam p le Report Description China Genet ic Test ing Market Trends : In an e f fo r t t o expand i t s domest ic b io techno logy sec to r , t he Ch inese Government has taken s teps in the favor o f gene t i c sc ience deve lopment . I t iden t i f i ed genomics as a s t ra teg ic f i e ld fo r t he coun t ry ’ s soc ia l and economic deve lopment in i t s 14 th F ive -Year P lan . The Government a lso p lans to document the gene t i c makeup o f peop le f rom n ine d i f f e ren t m inor i t y g roups , in an a t tempt to decode hered i ta ry in fo rma t ion w i th in the i r genes . Apa r t f rom th is , t he marke t f o r d i rec t - to -consumer DNA tes t ing has a lso exper ienced mass ive g rowth d r i ven by r i s ing p r io r i t y o f pe rsona l hea l th and we l lness among consumers . Th is t rend has fu r the r been suppor ted by techno log ica l advancements wh ich have reduced the cos t o f DNA sequenc ing se rv i ces . However , t he re is a lack o f spec i f i ca l l y -des igned educa t iona l p rograms fo r t ra in ing med ica l gene t i c p ro fess iona ls in Ch ina . Look ing forward, the market va lue is expected to reach US$ 14 .9 B i l l ion by 2032 , exhib i t ing a CAGR of 14 .4% dur ing 2024-2032 . V iew Repor t TOC, F igures and Tables : h t tps: / /www. imarcgroup.com/china-genet ic - tes t ing-market Breakup by Test Type: • Prenatal Test ing • Carr ier Test ing • New Born Test ing • Predict ive/Presymptomatic Test ing • Diagnost ic Test ing • Others Report Segmentation Breakup by Disease: • Cancer • Down Syndrome • Thalassemia • Others Breakup by Technology: • Biochemical • Molecular • Cytogenetic Breakup by Service Provider: • Hospital Based Laboratories • Independent Laboratories Report • Specialty Cl inics Segmentation Breakup by Testing Sample: • Blood • Sal iva • Hair • Others • BGI • Berry Genomics Co. l td. • Daan Gene Co. Ltd Competitive • WuXi NextCODE Landscape • Annoroad Gene Technology Co. Ltd. with Key • WuXi PharmaTech Players What was the size of the China genetic testing market in 2023? What is the expected growth rate of the China genetic testing market during 2024-2032? Key Questions What are the key factors driving the China genetic testing market? Answered in What has been the impact of COVID-19 on the the Report China genetic testing market? What is the breakup of the China genetic testing market based on the test type? What is the breakup of the China genetic testing market based on the disease? What is the breakup of the China genetic testing market based on technology? What is the breakup of the China genetic testing market based on the service provider? Key Questions What is the breakup of the China genetic testing market based on the testing sample? Answered in Who are the key players/companies in the China the Report genetic testing market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n 2 . 4 . 1 B o t t o m - U p A p p r o a c h Table of 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n 4 . 1 O v e r v i e w Contents 4 . 2 K e y I n d u s t r y T r e n d s5 C h i n a G e n e t i c T e s t i n g M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t B r e a k u p b y T e s t T y p e 5 . 5 M a r k e t B r e a k u p b y D i s e a s e 5 . 6 M a r k e t B r e a k u p b y T e c h n o l o g y 5 . 7 M a r k e t B r e a k u p b y S e r v i c e P r o v i d e r 5 . 8 M a r k e t B r e a k u p b y T e s t i n g S a m p l e 5 . 9 M a r k e t F o r e c a s t 5 . 1 0 S W O T A n a l y s i s 5 . 1 0 . 1 O v e r v i e w 5 . 1 0 . 2 S t r e n g t h s 5 . 1 0 . 3 W e a k n e s s e s 5 . 1 0 . 4 O p p o r t u n i t i e s 5 . 1 0 . 5 T h r e a t s 5 . 1 1 V a l u e C h a i n A n a l y s i s 5 . 1 1 . 1 R e s e a r c h a n d D e v e l o p m e n t 5 . 1 1 . 2 E q u i p m e n t ' s P r o c u r e m e n t 5 . 1 1 . 3 S a m p l e s C o l l e c t i o n 5 . 1 1 . 4 G e n e t i c T e s t i n g 5 . 1 1 . 5 D a t a A n a l y s i s a n d I n t e r p r e t a t i o n 5 . 1 1 . 6 R e c e i v i n g C o m p r e h e n s i v e 5 . 1 1 . 7 C l i n i c a l R e p o r t 5 . 1 2 P o r t e r s F i v e F o r c e s A n a l y s i s 5 . 1 2 . 1 O v e r v i e w 5 . 1 2 . 2 B a r g a i n i n g P o w e r o f B u y e r s Table of 5 . 1 2 . 3 B a r g a i n i n g P o w e r o f S u p p l i e r s 5 . 1 2 . 4 D e g r e e o f C o m p e t i t i o n 5 . 1 2 . 5 T h r e a t o f N e w E n t r a n t s 5 . 1 2 . 6 T h r e a t o f S u b s t i t u t e s Contents 5 . 1 3 K e y S u c c e s s a n d R i s k F a c t o r s 6 M a r k e t B r e a k u p b y T e s t T y p e 6 . 1 P r e n a t a l T e s t i n g 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 C a r r i e r T e s t i n g 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 N e w B o r n T e s t i n g 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 P r e d i c t i v e / P r e s y m p t o m a t i c T e s t i n g 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /c h in a -g ene t i c - t e s t i ng -m a rke t / t o c Partial List of Clients Partial List of Clients Disclaimer © 2024 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com +1-631-791-1145 [email protected] Stay With Us:
Comments